News

Bhad Bhabie was spotted out with her friends in Los Angeles over the weekend after revealing she got a nose job.
  • January 26, 2025
  • 0 Comment
Read More
Erika Jayne's son, LAPD officer Thomas 'Tommy' Zizzo, testified in Los Angeles on Friday in the gun trial of rapper A$AP Rocky. Zizzo, 32, was the first witness called in the highly publicized case.
  • January 26, 2025
  • 0 Comment
Read More
NPR's Scott Detrow talks with Trey Kay, host of the podcast Us & Them from West Virginia Public Broadcasting, which focuses on the issues that are dividing America.
  • January 26, 2025
  • 0 Comment
Read More
Dave Franco, Somebody I Used To Know, Premiere, 2023 After a shocking murder that captivated the nation, Dave Franco started receiving texts saying the same thing about him. His of his friends and acquaintances jokingly informed him he looks like...
  • January 26, 2025
  • 0 Comment
Read More
Sharon Baldoni, Justin Baldoni, Throwback, Instagram, 2025 Justin Baldoni's mother has her son's back. As the It Ends With Us director faces a legal battle against costar Blake Lively, who has sued him for alleged sexual harassment and retaliation, his...
  • January 25, 2025
  • 0 Comment
Read More
Gypsy Rose Blanchard, 2025 Gypsy Rose Blanchard is laying the rumors to rest. Weeks after welcoming baby daughter Aurora Urker, her first child with boyfriend Ken Urker, the 33-year-old spoke out about what she dubbed...
  • January 25, 2025
  • 0 Comment
Read More
Shemar Moore, Jesiree Dizon Shemar Moore is swatting away the idea of expanding his family.  The Criminal Minds alum revealed he has no plans to have a second baby with girlfriend Jesiree Dizon, with whom he already shares...
  • January 25, 2025
  • 0 Comment
Read More
Sandra Bullock has been bizarrely dragged into Ryan Reynolds and Blake Lively's legal drama with It Ends With Us star Justin Baldoni courtesy of an unearthed post.
  • January 25, 2025
  • 0 Comment
Read More

Nature Medicine, Published online: 25 January 2025; doi:10.1038/s41591-024-03443-3

As presented at the 2025 ASCO GI Cancers Symposium: in the phase 3 BREAKWATER trial, patients with previously untreated BRAF V600E metastatic colorectal cancer received the BRAF inhibitor encorafenib, the anti-EGFR monoclonal antibody cetuximab and chemotherapy mFOLFOX6 versus investigator’s choice of chemotherapy with or without bevacizumab, leading to an improved objective response rate, with the dual primary endpoint of progression free survival still maturing.
  • January 25, 2025
  • 0 Comment
Read More
Ads
0
    0
    Your Cart
    Your cart is emptyReturn to Shop